2022
DOI: 10.1186/s12992-022-00801-z
|View full text |Cite
|
Sign up to set email alerts
|

COVAX, vaccine donations and the politics of global vaccine inequity

Abstract: Background In 2021, donor countries, the pharmaceutical industry, and the COVAX initiative promoted vaccine donation or “dose-sharing” as a main solution to the inequitable global distribution of Covid-19 vaccines. COVAX positioned itself as a global vaccine-sharing hub that promised to share doses “equitably, effectively and transparently,” according to rational criteria overseen by independent scientists. This article provides a critical analysis of the principles and practice of “dose-sharin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
70
0
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(73 citation statements)
references
References 22 publications
0
70
0
3
Order By: Relevance
“…For example, the contracts between vaccine manufacturers and the US Federal government included clauses such as ‘The Government may not use, or authorise the use of, any products or materials provided under this Project Agreement, unless such use occurs in the United States or U.S. territories’. 24 Further, to complement manufacturers’ printed expiry dates, the Vaccine Presentation and Packaging Advisory Group, 25 UNICEF and other LMIC vaccine delivery-focused agencies should accelerate the use of electronic lookup of expiry date for new vaccines where stability has not yet been fully established. Dynamic lookup of expiry date based on batch number avoids the problem of static printed expiry dates, and allows for dynamically adjusting the expiry date when new stability information to extend shelf-life becomes available.…”
Section: Practical Actions To Reduce Vaccine Wastagementioning
confidence: 99%
See 1 more Smart Citation
“…For example, the contracts between vaccine manufacturers and the US Federal government included clauses such as ‘The Government may not use, or authorise the use of, any products or materials provided under this Project Agreement, unless such use occurs in the United States or U.S. territories’. 24 Further, to complement manufacturers’ printed expiry dates, the Vaccine Presentation and Packaging Advisory Group, 25 UNICEF and other LMIC vaccine delivery-focused agencies should accelerate the use of electronic lookup of expiry date for new vaccines where stability has not yet been fully established. Dynamic lookup of expiry date based on batch number avoids the problem of static printed expiry dates, and allows for dynamically adjusting the expiry date when new stability information to extend shelf-life becomes available.…”
Section: Practical Actions To Reduce Vaccine Wastagementioning
confidence: 99%
“…Furthermore, manufacturers of vaccines should continue to apply for shelf-life extensions and remove any contractual barriers impeding donating to LMIC. For example, the contracts between vaccine manufacturers and the US Federal government included clauses such as ‘The Government may not use, or authorise the use of, any products or materials provided under this Project Agreement, unless such use occurs in the United States or U.S. territories’ 24. Further, to complement manufacturers’ printed expiry dates, the Vaccine Presentation and Packaging Advisory Group,25 UNICEF and other LMIC vaccine delivery-focused agencies should accelerate the use of electronic lookup of expiry date for new vaccines where stability has not yet been fully established.…”
Section: Practical Actions To Reduce Vaccine Wastagementioning
confidence: 99%
“…Covax was pushed to the back of the queue with manufacturers, so donations from rich countries became the mainstay for the global south until the second quarter of 2022. A recent analysis from the University of Oslo estimates that donated doses account for roughly 60% of the doses Covax delivered in 2021 3…”
Section: Eu Promisementioning
confidence: 99%
“…Similarly, impacts on overbuying could go either way: essentially such a mechanism would allow buyers to choose their own balance of supply security/diversity versus cost. The resale market should have one advantage over donations, however: it should disincentivize the dumping of soonto-expire or less desired products only when APA holders are absolutely sure they will not need them [51]. One potential challenge to this solution is the reluctance of some suppliers to allow secondary markets: it has been alleged that many COVID-19 vaccine suppliers prohibited resale of products within the terms of their APAs [52].…”
Section: Resale Marketmentioning
confidence: 99%